James Louis Januzzi Jr., M.D.
Co-Author
This page shows the publications co-authored by James Januzzi and Cian McCarthy.
Connection Strength
18.604
-
Periprocedural MI as an Endpoint in Clinical Trials: A Proposed Path Forward. J Am Coll Cardiol. 2022 02 15; 79(6):527-529.
Score: 0.987
-
Untangling Myocardial Injury: Moving From Consequence to Cause. J Am Coll Cardiol. 2021 08 24; 78(8):791-793.
Score: 0.955
-
Patient Characteristics and Clinical Outcomes of Type 1 Versus Type 2 Myocardial Infarction. J Am Coll Cardiol. 2021 02 23; 77(7):848-857.
Score: 0.922
-
Increasingly Sensitive Troponin Assays: Is Perfect the Enemy of Good? J Am Heart Assoc. 2020 12; 9(23):e019678.
Score: 0.907
-
Derivation and External Validation of a High-Sensitivity Cardiac Troponin-Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease. J Am Heart Assoc. 2020 08 18; 9(16):e017221.
Score: 0.888
-
Cardiac Troponin and the True False Positive. JACC Case Rep. 2020 Mar; 2(3):461-463.
Score: 0.864
-
Myocardial Injury in the Era of High-Sensitivity Cardiac Troponin Assays: A Practical Approach for Clinicians. JAMA Cardiol. 2019 10 01; 4(10):1034-1042.
Score: 0.837
-
Passivating High-Risk Plaques: Try, Try Again. JACC Cardiovasc Imaging. 2020 07; 13(7):1561-1563.
Score: 0.830
-
Trivializing an Elevated Troponin: Adding Insult to Injury? J Am Coll Cardiol. 2019 01 08; 73(1):10-12.
Score: 0.796
-
Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170.
Score: 0.777
-
Type 2 Myocardial Infarction-Diagnosis, Prognosis, and Treatment. JAMA. 2018 Aug 07; 320(5):433-434.
Score: 0.773
-
A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul; 41(7):903-909.
Score: 0.765
-
Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study. J Am Heart Assoc. 2018 03 08; 7(6).
Score: 0.751
-
Evaluating Chest Pain in the Emergency Department: Searching for the Optimal Gatekeeper. J Am Coll Cardiol. 2018 02 13; 71(6):617-619.
Score: 0.748
-
Soluble ST2 in Heart Failure. Heart Fail Clin. 2018 Jan; 14(1):41-48.
Score: 0.742
-
Biomarkers in stable coronary artery disease. Am Heart J. 2018 02; 196:82-96.
Score: 0.733
-
Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). Am J Cardiol. 2017 07 01; 120(1):25-32.
Score: 0.705
-
Relation of High-Sensitivity Cardiac Troponin I and Obstructive Coronary Artery Disease in Patients Without Acute Myocardial Infarction. Am J Cardiol. 2022 Mar 28.
Score: 0.249
-
Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes. J Am Coll Cardiol. 2021 09 21; 78(12):1242-1253.
Score: 0.240
-
The Intersection of Type 2 Myocardial Infarction and Heart Failure. J Am Heart Assoc. 2021 09 07; 10(17):e020849.
Score: 0.239
-
A Test in Context: Interpretation of High-Sensitivity Cardiac Troponin Assays in Different Clinical Settings. J Am Coll Cardiol. 2021 03 16; 77(10):1357-1367.
Score: 0.232
-
Cardiologist Evaluation of Patients With Type 2 Myocardial Infarction. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e007440.
Score: 0.226
-
Early clinical and sociodemographic experience with patients hospitalized with COVID-19 at a large American healthcare system. EClinicalMedicine. 2020 Sep; 26:100504.
Score: 0.223
-
Home-Time After Discharge Among Patients With Type 2 Myocardial Infarction. J Am Heart Assoc. 2020 05 18; 9(10):e015978.
Score: 0.218
-
Inflammation in Heart Failure: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020 03 24; 75(11):1324-1340.
Score: 0.216
-
Sex Differences in Patient Characteristics, Treatment Strategies, and Outcomes for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 06 25; 73(24):3230-3232.
Score: 0.205
-
Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019 05 07; 73(17):2135-2145.
Score: 0.204
-
Misclassification of Myocardial Injury as Myocardial Infarction: Implications for Assessing Outcomes in Value-Based Programs. JAMA Cardiol. 2019 05 01; 4(5):460-464.
Score: 0.203
-
Association of the New Peer Group-Stratified Method With the Reclassification of Penalty Status in the Hospital Readmission Reduction Program. JAMA Netw Open. 2019 04 05; 2(4):e192987.
Score: 0.202
-
Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. J Am Coll Cardiol. 2019 03 26; 73(11):1273-1284.
Score: 0.202
-
Left Ventricular Thrombus: Contemporary Etiologies, Treatment Strategies, and Outcomes. J Am Coll Cardiol. 2019 04 23; 73(15):2007-2009.
Score: 0.201
-
Underutilization of Cardiac Rehabilitation for Type 2 Myocardial Infarction. J Am Coll Cardiol. 2019 04 23; 73(15):2005-2007.
Score: 0.201
-
A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography. Clin Cardiol. 2019 Feb; 42(2):292-298.
Score: 0.199
-
Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019 03; 209:36-46.
Score: 0.198
-
Multiple biomarker panel to screen for severe aortic stenosis: results from the CASABLANCA study. Open Heart. 2018; 5(2):e000916.
Score: 0.196
-
Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Chem. 2018 11; 64(11):1617-1625.
Score: 0.195
-
Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment. JAMA Cardiol. 2018 07 01; 3(7):642-649.
Score: 0.192
-
Type 2 Myocardial Infarction - An Evolving Entity. Circ J. 2018 01 25; 82(2):309-315.
Score: 0.186
-
Application of the GRACE, TIMI, and TARRACO Risk Scores in Type 2 Myocardial Infarction. J Am Coll Cardiol. 2020 01 28; 75(3):344-345.
Score: 0.053
-
Prescription of Glucagon-Like Peptide-1 Receptor Agonists by Cardiologists. J Am Coll Cardiol. 2019 04 02; 73(12):1596-1598.
Score: 0.051
-
Prescriber Patterns of SGLT2i After Expansions of U.S. Food and Drug Administration Labeling. J Am Coll Cardiol. 2018 12 25; 72(25):3370-3372.
Score: 0.050
-
Delirium in the Cardiac Intensive Care Unit. J Am Heart Assoc. 2018 02 16; 7(4).
Score: 0.047
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.